Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 4 months ago
Share
To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
277 patients around the world
Available in
Spain, Argentina, United States
Immunovant Sciences GmbH
277
Patients around the world
This study is for people with
Polyneuropathies
Demyelinating polyneuropathies
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Sponsor
Immunovant Sciences GmbH
Conditions
Demyelinating polyneuropathies
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05581199
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent